# Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

> **NCT03047772** · PHASE2 · UNKNOWN · sponsor: **Yuejin Yang** · enrollment: 124 (estimated)

## Conditions studied

- Myocardial Infarction
- Stem Cell Transplantation
- Angioplasty, Transluminal, Percutaneous Coronary

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Intensive Atorvastatin
- **DRUG:** Low dose BMMSC
- **DRUG:** Middle dose BMMSC
- **DRUG:** High dose BMMSC
- **DRUG:** Transplantation

## Key facts

- **NCT ID:** NCT03047772
- **Lead sponsor:** Yuejin Yang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-06
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047772, "Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03047772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*